RETRACTED: MIG-7 Controls COX-2/PGE2-Mediated Lung Cancer Metastasis (Retracted article. See vol. 79, pg. 4553, 2019)

被引:45
作者
Ho, Ming-Yi [1 ]
Liang, Shu-Mei [1 ,2 ]
Hung, Shao-Wen [2 ]
Liang, Chi-Ming [1 ,2 ,3 ]
机构
[1] Acad Sinica, Genom Res Ctr, Taipei 11529, Taiwan
[2] Acad Sinica, ABRC, Taipei 11529, Taiwan
[3] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan
关键词
CELL-SPECIFIC MIG-7; MATRIX-METALLOPROTEINASE; TUMOR-GROWTH; CARCINOMA; AKT; EXPRESSION; INVASION; COX-2; CYCLOOXYGENASE-2; ACTIVATION;
D O I
10.1158/0008-5472.CAN-12-2220
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
More effective treatments for metastatic lung cancer remain a pressing clinical need. In this study, we identified migration inducting gene-7 (MIG-7) protein as critical for COX-2/prostaglandin E2 (PGE2)- and Akt/GSK-3 beta-dependent tumor invasion/metastasis. COX-2/PGE2 activated EP4 to enhance Akt and GSK-3 beta phosphorylation and beta-catenin/T-cell factor/lymphoid enhancer factor signaling leading to MIG-7 upregulation. RNAi-mediated attenuation of MIG-7 blocked COX-2/PGE2-and Akt/GSK-3 beta-mediated migration/invasion effects. Furthermore, MIG-7 protein inhibited protein phosphatase 2A to sustain Akt/GSK-3 beta phosphorylation and cancer-cell migration/invasion. Cancer cells overexpressing MIG-7 exhibited increased expression of ZEB-1 and Twist in parallel with epithelial-mesenchymal transition, metastasis and cancer lethality. MIG-7 protein level positively correlated with advanced stages of human lung cancers. MIG-7 thus offers a theranostic target for cancer metastases arising from aberrant activation of the cellular COX-2/PGE2 and Akt/GSK-3 beta signaling pathways. Cancer Res; 73(1); 439-49. (C)2012 AACR.
引用
收藏
页码:439 / 449
页数:11
相关论文
共 39 条
[31]   Complex networks orchestrate epithelial-mesenchymal transitions [J].
Thiery, JP ;
Sleeman, JP .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2006, 7 (02) :131-142
[32]   Vioxx withdrawal alarms cancer prevention researchers [J].
Vanchieri, C .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (23) :1734-1735
[33]   PI3K/Akt signalling pathway and cancer [J].
Vara, JAF ;
Casado, E ;
de Castro, J ;
Cejas, P ;
Belda-Iniesta, C ;
González-Barón, M .
CANCER TREATMENT REVIEWS, 2004, 30 (02) :193-204
[34]   Eicosanoids and cancer [J].
Wang, Dingzhi ;
Dubois, Raymond N. .
NATURE REVIEWS CANCER, 2010, 10 (03) :181-193
[35]   Multiple pathways regulated by the tumor suppressor PP2A in transformation [J].
Westermarck, Jukka ;
Hahn, William C. .
TRENDS IN MOLECULAR MEDICINE, 2008, 14 (04) :152-160
[36]  
Wolff H, 1998, CANCER RES, V58, P4997
[37]   Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis [J].
Yang, J ;
Mani, SA ;
Donaher, JL ;
Ramaswamy, S ;
Itzykson, RA ;
Come, C ;
Savagner, P ;
Gitelman, I ;
Richardson, A ;
Weinberg, RA .
CELL, 2004, 117 (07) :927-939
[38]   Allosteric AKT inhibitors as a targeted cancer therapy [J].
Yun, Jihye .
CANCER BIOLOGY & THERAPY, 2010, 9 (07) :504-506
[39]   Adverse effects of cyclooxygenase 2 inhibitors on renal and arrhythmia events - Meta-analysis of randomized trials [J].
Zhang, Jingjing ;
Ding, Eric L. ;
Song, Yiqing .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (13) :1619-1632